A Comparison of the Costs Associated with the Administration of Select High-cost Infused Medications in Three Sites of Care for a State Medicaid Population

Wednesday, April 25, 2018
Poster image
Sage Bagwell, PharmD
University of Massachusetts Medical School
Pavel Lavitas, PharmD, BCPS
University of Massachusetts Medical School
Thomas Pomfret, PharmD, MPH, BCPS
University of Massachusetts Medical School
Bonnie Greenwood, PharmD, BCPS
University of Massachusetts Medical School
Stephanie Tran, PharmD
University of Massachusetts Medical School
Nancy Schiff, MPH
University of Massachusetts Medical School
Tasmina Hydery, PharmD, MBA, CGP
University of Massachusetts Medical School
Patricia Leto, PharmD
University of Massachusetts Medical School
Mylissa Price, MPH, BS, RPh
University of Massachusetts Medical School
Caroline J. Alper, MD
University of Massachusetts Medical School
Kimberly Lenz, PharmD
University of Massachusetts Medical School
Paul L. Jeffrey, PharmD
University of Massachusetts Medical School

This poster evaluates the financial impact of high-cost infused medications across three site of care programs. Site of care programs help payers save money on specialty drug spend by shifting utilization on high costs infused medications to less costly sites of administration. The objective of this project was to evaluate the costs associated with the administration of select high-cost infused medications in site of care programs in Massachusetts Medicaid populations. Research was done through retrospective analysis that included pharmacy and medical claims data for select high cost infused medications between April 1, 2017 - September 20, 2017. 

This presentation was given at the 2018 Managed Care & Specialty Pharmacy Annual Meeting and received the AMCP Foundation Best Poster Award in the Resident and Fellows category. 

Conference 
2018 Managed Care & Specialty Pharmacy Annual Meeting